NCT04969848

Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device

Uncontrolled, Single-center Study to Quantify Gait Disturbance in Patients With Multiple Sclerosis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 44 (actual)
• Sponsor: Nantes University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Not accepted

Summary

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. The development of wearable device offers the opportunity to collect data during daily activity including walking.

Detailed description

Umanit and LMJ (Nantes university) has developed a device call eMSgait to assess walking ability in MS patients individuals (eg MS patients). This device consists in a commercialized IMU sensor (MetaMotionR Sensor, Mbientilab) worn at the right hip, a smartphone app and dedicated algorithm/mathematical model to extract raw sensor data and calculate individual gait pattern (IGP). This IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle. Pursue first pilot work assessing information from IGP on gait alteration in MS.

Conditions

• Multiple Sclerosis

Interventions

Type	Name	Description
OTHER	Wearable sensor	IMU sensor (as part of eMSGait device) worn at the hip during T25FW

Timeline

• Start date: 2021-08-18
• Primary completion: 2022-05-31
• Completion: 2022-05-31
• First posted: 2021-07-21
• Last updated: 2022-06-03

Locations

1 site across 1 country: France